B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CSNK2A3

MOLECULAR TARGET

casein kinase 2 alpha 3

UniProt: Q8NEV1NCBI Gene: 2831069 compounds

CSNK2A3 (casein kinase 2 alpha 3) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CSNK2A3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as1.393
2Apigenin 5,7,4'-trihydroxy-flavone,1.102
3Kaempferols1.102
4Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.102
5Quercetin1.102
6Vanillic Acid1.102
7chrysin0.691
8fisetin0.691
9myricetin-3-O-galactopyranoside [Supplementary Concept]0.691

About CSNK2A3 as a Drug Target

CSNK2A3 (casein kinase 2 alpha 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented CSNK2A3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CSNK2A3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.